公众号 / 文章复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒性休克患者抢救过程的思考

[Thoughts on the rescue process of a patient with septic shock].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论脓毒性休克液体复苏后血压不升需考虑脓毒症心肌病,增加多巴酚丁胺并降低前负荷可稳定循环。

本文报道2023年10月2日民航总医院重症医学科收治的1例52岁女性脓毒性休克患者,液体复苏后尿量从40 mL/h增至100 mL/h但血压无明显升高,加用多巴酚丁胺3 μg×kg-1×min-1后心率无明显增加、血压相对稳定。入ICU 21小时收缩压由110-120 mmHg骤降至60-70 mmHg、心率由100-110 bpm降至80-90 bpm,去甲肾上腺素增至2 μg×kg-1×min-1、多巴酚丁胺增至10 μg×kg-1×min-1仍不能维持循环,排除张力性气胸、急性失血、急性心肌梗死及肺动脉高压后考虑脓毒症心肌病。将多巴酚丁胺泵入剂量增至20 μg×kg-1×min-1、减慢输液速度、降低心脏前负荷并继续使用血管活性药物约1小时后血压回升、循环稳定,抢救成功。

要点

  • 脓毒性休克液体复苏后尿量由40 mL/h增至100 mL/h但血压无明显升高,提示无容量反应性,加用多巴酚丁胺3 μg×kg-1×min-1增强心肌收缩力。
  • 入ICU 21小时收缩压由110-120 mmHg骤降至60-70 mmHg、心率由100-110 bpm降至80-90 bpm,去甲肾上腺素增至2 μg×kg-1×min-1、多巴酚丁胺增至10 μg×kg-1×min-1仍不能维持循环。
  • 排除张力性气胸、急性失血、急性心肌梗死及肺动脉高压后,考虑血压下降由心功能下降所致,合并脓毒症心肌病。
  • 多巴酚丁胺泵入剂量增至20 μg×kg-1×min-1、减慢输液速度、降低心脏前负荷并继续血管活性药物约1小时后血压回升、循环稳定。
  • 维持血压的三要素为有效循环血容量、心功能和外周血管阻力,脓毒性休克维持循环的难点是正确找出哪一个是主要问题。

适用人群与场景

  • 重症医学科收治的脓毒性休克成人患者,本例为52岁女性,主诉左面部麻木20余天、加重伴意识不清5天,入院时昏迷、经口气管插管。

诊断标准与关键阈值

  • 入ICU 12小时动脉与中心静脉血气分析:氧摄取率31%(>30%)、静脉-动脉血二氧化碳分压差(Pv-aCO2)7 mmHg(>6 mmHg)、血乳酸升高,结合下腔静脉宽度1.0-1.6 cm,提示有效循环血容量相对不足。

处置流程与药物剂量

  • 入ICU 12小时根据氧摄取率31%、Pv-aCO2 7 mmHg、血乳酸升高及下腔静脉宽度1.0-1.6 cm给予适当液体复苏。
  • 液体复苏后尿量由40 mL/h增至100 mL/h但血压无明显升高、无容量反应性,加用多巴酚丁胺3 μg×kg-1×min-1增强心肌收缩力。
  • 入ICU 21小时收缩压由110-120 mmHg降至60-70 mmHg、心率由100-110 bpm降至80-90 bpm,去甲肾上腺素剂量增至2 μg×kg-1×min-1、多巴酚丁胺增至10 μg×kg-1×min-1。
  • 考虑脓毒症心肌病后,将多巴酚丁胺泵入剂量增至20 μg×kg-1×min-1、减慢输液速度、降低心脏前负荷,并继续使用血管活性药物升压约1小时。

红旗征与不能漏的情况

  • 入ICU 21小时收缩压突然由110-120 mmHg降至60-70 mmHg、心率由100-110 bpm降至80-90 bpm,增加去甲肾上腺素至2 μg×kg-1×min-1及多巴酚丁胺至10 μg×kg-1×min-1后循环仍不能维持。
  • 需排除张力性气胸(胸部X线未见)、急性失血(血常规不支持)、急性心肌梗死(心肌酶学变化不符合)及肺动脉高压(心脏彩超未见)。

研究设计与关键结果

  • 本例为52岁女性脓毒性休克患者,2023年10月2日收入民航总医院重症医学科,主要诊断为脓毒性休克、肺炎、左侧脑桥臂急性脑梗死等。
  • 入ICU时血压128/82 mmHg(去甲肾上腺素0.2 μg×kg-1×min-1静脉泵入),胸部CT示肺部感染、感染标志物升高。
  • 入ICU 12小时氧摄取率31%(>30%)、Pv-aCO2 7 mmHg(>6 mmHg)、血乳酸升高、下腔静脉宽度1.0-1.6 cm。
  • 液体复苏后尿量由40 mL/h增至100 mL/h,血压无明显升高。
  • 入ICU 21小时收缩压由110-120 mmHg降至60-70 mmHg、心率由100-110 bpm降至80-90 bpm;肌钙蛋白I由3 778.8 ng/L降至2 025.9 ng/L,脑钠肽由15 ng/L升至1 638 ng/L。
  • 多巴酚丁胺增至20 μg×kg-1×min-1、减慢输液速度、降低心脏前负荷并继续血管活性药物约1小时后血压回升、循环稳定。
  • 治疗60天后肺炎有效控制,血管活性药物及多巴酚丁胺成功停用,拔除气管插管,出院时可辅助短距离行走。

证据类型、等级与局限

  • 病例报告(单例)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 脓毒性休克液体复苏后尿量增加但血压不升提示无容量反应性,作者考虑加用多巴酚丁胺增强心肌收缩力。
  • 循环不能维持时需排除张力性气胸、急性失血、急性心肌梗死及肺动脉高压,并考虑脓毒症心肌病可能。
  • 作者认为个体化容量管理、正确识别与处理心功能障碍、合理使用血管活性药物是维持脓毒性休克患者循环的关键。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Septic shock is a common acute and critical illness in intensive care medicine. It can lead to multiple organ failure, of which the heart is one of the target organs. Fluid resuscitation plays an important role in the treatment of septic shock, but when a patient develops septic-induced cardiomyopathy, the circulation is often not improved by fluid resuscitation, and may even lead to deterioration of circulation. On October 2, 2023, a 52-year-old female patient with septic shock was admitted to the department of intensive care medicine of Civil Aviation General Hospital, whose circulation deteriorated during fluid resuscitation. The main complaint of the patient was left face numbness for more than 20 days, aggravated with unconsciousness for 5 days. Upon admission, the patient was in a coma and intubated by oral tube. The blood pressure was 128/82 mmHg (1 mmHg ≈ 0.133 kPa; intravenous pump of norepinephrine 0.2 μg×kg-1×min-1). Chest CT indicated lung infection, and infection markers were elevated. The main diagnoses were septic shock, pneumonia, acute cerebral infarction of left pontine arm and etc. At 12 hours after admission, according to arterial and central vein blood gas analyses, the oxygen uptake rate was 31% (> 30%), and the veno-arterial blood partial pressure of carbon dioxide (Pv-aCO2) was 7 mmHg (> 6 mmHg), blood lactic acid (Lac) increased, combined with the width of the inferior vena cava of 1.0-1.6 cm, also indicated a relative insufficiency of effective circulating blood volume, so appropriate fluid resuscitation was given. After fluid resuscitation, the urine volume of the patient increased from 40 mL/h to 100 mL/h, but the blood pressure did not increase significantly, indicating that there was no volume responsiveness, so dobutamine 3 μg×kg-1×min-1 was added to enhance myocardial contractility. The heart rate did not increase significantly, and the blood pressure was relatively stable. At 21 hours after admission, the patient's systolic blood pressure (SBP) suddenly dropped from 110-120 mmHg to 60-70 mmHg, while heart rate dropped from 100-110 bpm to 80-90 bpm. Therefore, the dosage of norepinephrine was increased to 2 μg×kg-1×min-1, and the dosage of dobutamine was increased to 10 μg×kg-1×min-1, but the circulation could not be maintained. In addition, no tension pneumothorax was found in the chest radiography, and blood routine did not indicate the possibility of acute blood loss. Troponin I (TnI) decreased from 3 778.8 ng/L to 2 025.9 ng/L, brain natriuretic peptide (BNP) increased from 15 ng/L to 1 638 ng/L. Myocardial enzymology changes were not consistent with acute myocardial infarction, and pulmonary hypertension was not found in cardiac color ultrasound. Therefore, it is considered that the decrease of blood pressure was caused by the decrease of cardiac function, which was combined with septic cardiomyopathy. After increasing the dobutamine pump dose to 20 μg×kg-1×min-1, lowering the infusion speed, reducing the cardiac preload, and continuing to use vasoactive drugs to boost blood pressure for about 1 hour, the patient's blood pressure increased, circulation became stable, and the rescue was successful. After 60 days of treatment, the pneumonia of the patient was effectively controlled, vasoactive drugs and dobutamine were successfully stopped, the patient was extubated, and was able to walk short distances with assistance when discharged. When the circulation of septic shock patients cannot be maintained, the three elements of maintaining blood pressure are effective circulating blood volume, cardiac function and peripheral vascular resistance. The three elements interact with each other and are affected by various factors. The difficulty of maintaining circulation in septic shock is to find out which is the main problem correctly. Individualized volume management, correct recognition and treatment of cardiac dysfunction, and rational use of vasoactive drugs are the keys to maintain circulation in septic shock patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Dong J, Zheng Y. [Thoughts on the rescue process of a patient with septic shock]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 39968591. doi:10.3760/cma.j.cn121430-20240709-00576

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。